BVS FDA Reclassifies Exogen to Class II, CMS Updates Billing Rules, Reiterates 2026 Guidance
Bioventus Inc. Class A Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $7.93
-6.3% in 3d after detection
Post-detection moves
1h
—
1d
-2.3%
3d
-6.3%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS